Table 6.
Factors associated with service use in the 12 months of life, N = 68,523
| Variable | Value | GP consultationa | GP prescriptionb | ||
|---|---|---|---|---|---|
| Palliative care | Yes | 1.30(1.29 to 1.32) | < 0.0001 | 1.17(1.16 to 1.18) | < 0.0001 |
| Age at death (ref: < 50) | 50–59 | 0.98(0.95 to 1.01) | < 0.0001 | 1.09(1.04 to 1.13) | < 0.0001 |
| 60–69 | 0.97(0.95 to 1.00) | 1.21(1.16 to 1.25) | |||
| 70–79 | 0.95(0.93 to 0.98) | 1.26(1.22 to 1.31) | |||
| 80–89 | 0.90(0.88 to 0.93) | 1.28(1.23 to 1.33) | |||
| 90+ | 0.85(0.83 to 0.88) | 1.34(1.29 to 1.40) | |||
| Gender (ref: female) | Male | 0.96(0.95 to 0.97) | < 0.0001 | 0.93(0.91 to 0.94) | < 0.0001 |
| Cancer site (ref: Lung) | Colorectal | 1.01(1.00 to 1.03) | < 0.0001 | 1.06(1.04 to 1.08) | < 0.0001 |
| Breast | 1.04(1.03 to 1.05) | 0.97(0.96 to 0.99) | |||
| Prostate | 1.22(1.20 to 1.24) | 1.15(1.13 to 1.17) | |||
| No. comorbidity conditions (ref: 0) | 1 | 1.09(1.08 to 1.11) | < 0.0001 | 1.20(1.18 to 1.22) | < 0.0001 |
| 2 | 1.21(1.19 to 1.22) | 1.43(1.40 to 1.45) | |||
| 3 | 1.30(1.28 to 1.32) | 1.62(1.59 to 1.65) | |||
| 4+ | 1.42(1.39 to 1.44) | 1.92(1.88 to 1.95) | |||
| Time between diagnosis and death (months) (ref: 120+) | < 6 | 1.06(1.03 to 1.09) | < 0.0001 | 0.99(0.95 to 1.02) | |
| 6–12 | 1.27(1.23 to 1.31) | 1.09(1.05 to 1.12) | < 0.0001 | ||
| 13–36 | 1.09(1.06 to 1.11) | 1.06(1.03 to 1.10) | |||
| 37–60 | 1.04(1.01 to 1.07) | 1.04(1.01 to 1.07) | |||
| 61–120 | 1.00(0.97 to 1.03) | 1.00(0.97 to 1.03) | |||
| Year of death (ref: 2010–2014) | 2000–2004 | 0.63(0.61 to 0.65) | < 0.0001 | 0.82(0.81 to 0.84) | < 0.0001 |
| 2005–2009 | 0.87(0.85 to 0.88) | 0.93(0.91 to 0.94) | |||
| Region (ref: England) | Wales | 0.98(0.92 to 1.04) | < 0.0001 | 1.14(1.09 to 1.19) | < 0.0001 |
| Scotland | 1.13(1.06 to 1.20) | 0.98(0.94 to 1.02) | |||
| NI | 1.57(1.43 to 1.71) | 1.15(1.07 to 1.24) |
a including all consultations (i.e. direct & indirect patient contacts); bprescriptions of unique products only